PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non ...

Retrieved on: 2024-06-12 15:07:57

Tags for this article:

MicroRNA

PD-L1

Non-small-cell lung cancer

Programmed cell death protein 1

MiR-138

Cancer immunotherapy

MiR-206

Click the tags to see associated articles and topics

PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non .... View article details on hiswai:

Summary

The article discusses the role of miR-138 and miR-206 within the field of bioinformatics to potentially inhibit PD-L1/PD-1 pathways in non-small-cell lung cancer (NSCLC), relating directly to cancer immunotherapy by preventing T cell apoptosis. The tags, such as MicroRNA, PD-L1, and MiR-138, highlight key areas of focus in the investigation of dysregulated miRNAs within NSCLC.

Article found on: www.nature.com

View Original Article